1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsThis program offers Department of Defense funding through Concept Awards, Idea Development Awards, and Resource and Community Development Awards supporting rare cancer biology, therapies, AI/ML, research platforms, and community infrastructure.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Unspecified in snippet, but likely research institutions and small businesses engaged in relevant research. Confirm the full requirements in the official notice before applying.
FY26 Rare Cancers Research Program is funded by Department of Defense (DoD). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Concept Award (DoD Rare Cancers Research Program) is sponsored by Department of Defense (Congressionally Directed Medical Research Programs). This award supports highly innovative, untested, potentially groundbreaking novel concepts in rare cancers. Preliminary data are not required, and the award focuses on high-risk studies that could reveal entirely new avenues for investigation.
FY26 Rare Cancers Research Program (RCRP) Concept Award is sponsored by Department of Defense (DoD) Congressionally Directed Medical Research Programs (CDMRP). This award supports the initial exploration of highly innovative, untested, potentially ground-breaking novel concepts in rare cancers. The potential impact may be near-term or long-term but must move beyond a minor advancement and demonstrate the potential to lead to a fundamentally new strategy or approach. Must address focus areas like Biology, Preclinical Research Model, Therapy, or AI/ML Model.
The memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read articleThe Department's FY26 SBIR/STTR Release 3 opened June 24 with roughly 37 topics across DARPA, the Navy, the Air Force, and the defense components, all closing July 22. The compressed four-week window is unforgiving, but the bigger mistake founders make is treating every component the same. Here is how to read the release, the eligibility rules that disqualify good companies, and why the component you target matters more than the topic you pick.
Read article